News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Deals
How Much Rumored Suitors Like Sanofi Would Have To Pay For Sarepta
May 2, 2017
·
1 min read
Deals
Why M&A Hungry Sanofi Could be Gearing Up to Buy Sarepta
May 1, 2017
·
2 min read
Genetown
Here’s Why Sarepta May Be The Rarest Of Finds: A ‘Value’ Biotech Stock
May 1, 2017
·
1 min read
Business
M&A Speculation Begins as Sarepta CEO Puts in His Notice
April 28, 2017
·
2 min read
Business
Sarepta CEO Gives CMO Role to Former Amgen-Regeneron Alum
April 4, 2017
·
3 min read
Deals
Sarepta Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead for $125 Million
February 21, 2017
·
2 min read
FDA
Sarepta Under Pressure As Marathon Pharma Emflaza’s Wins FDA Approval for DMD
February 10, 2017
·
3 min read
Genetown
JPM17: Sarepta’s New Numbers Impress Investors, Stock Gained $300 Million Overnight
January 11, 2017
·
2 min read
Deals
With Donald Trump as President, Here’s What Biotech M&A and Drug Pricing Could Look Like (and Renewed Takeover Interest for Tesaro and Sarepta
November 11, 2016
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 30, 2026
July 1, 2026
·
1 min read
Press Releases
Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®
June 30, 2026
·
17 min read
Press Releases
Sarepta Therapeutics to Participate in Upcoming Investor Conferences
June 2, 2026
·
1 min read
Press Releases
Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
May 14, 2026
·
1 min read
Press Releases
Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments
May 7, 2026
·
19 min read
Press Releases
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
April 23, 2026
·
1 min read
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 31, 2026
April 1, 2026
·
1 min read
Press Releases
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
·
9 min read
Press Releases
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
·
1 min read
Press Releases
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
March 19, 2026
·
15 min read
